Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Results
Phase 3
This trial looked at pembrolizumab and chemotherapy for people with non small cell lung cancer that had spread to other parts of the body.
People could join the trial between 2015 and 2017. The team published results in 2020, 2021 and 2023.
There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 25 April 2015
Recruitment end: 2 February 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Clive Mulatero
Merck Sharp & Dohme Ltd
Last reviewed: 27 Jul 2026
CRUK internal database number: 14092
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
